期刊文献+

口服胰岛素治疗青少年功能性消化不良的疗效观察

Efficacy of Oral Insulin in Treatment of Juvenile Functional Dyspepsia
下载PDF
导出
摘要 目的探讨胰岛素口服治疗青少年功能性消化不良(FD)的临床疗效和安全性。方法将我院就诊的70例青少年FD患者随机分为对照组和治疗组各35例,对照组给予口服多潘立酮片,治疗组给予口服短效胰岛素0.9U(/kg.d),疗程28d。观察两组临床疗效情况,血糖、血清钾变化,并判定疗效和安全性。结果治疗28d后对照组和治疗组有效率分别为42.9%和88.6%,差异有统计学意义(P<0.01)。两组低血糖发生率、高血糖发生率均为0,治疗后血清钾差异无统计学意义(P>0.05)。结论口服胰岛素辅助治疗青少年FD临床疗效显著,安全性好。 Objective To investigate the clinical efficacy and safety of oral insulin for treatment of juvenile functional dyspepsia (FD). Methods In this pilot randomized controlled study,70 cases of juvenile FD patients in our hospital were randomly divided into control group and treatment group with 35 cases in each;The control group was given oral domperidone tablets and the treatment group was given oral short-acting insulin with dose of 0.9U/(kg'd) for 28 days. The clinical efficacy, changes of blood glucose and serum potassium of the two groups were observed to evaluate the efficacy and safety. Results The effective rates of the control group and the treatment group were 42.9% and 88.6% respectively after treatment of 28 days and the difference was statistically significant (P〈 0.01 ). The incidence of low blood glucose and high blood glucose were all zero in the two groups, and there was no significant difference in serum potassium after treatment (P〉0.05), Conclusion The adjuvant treatment of juvenile functional dyspepsia with oral insulin has significant clinical efficacy and good safety.
出处 《中国现代医生》 2011年第14期16-17,27,共3页 China Modern Doctor
基金 江西省九江市科学技术局支持项目(编号:2010J326)
关键词 胰岛素 口服 功能性消化不良 青少年 Insulin Oral Functional dyspepsia Juvenile
  • 相关文献

参考文献13

  • 1Beardsall K,Ogilvy-Stuart AL,Frystyk J,et al. Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-1 levels in very low birth weight infants[J]. J Pediatr, 2007,151 (6) :611-617.
  • 2Jebbink RJ,Samsom M,Bruijs PP,et al. Hyperglycemia induces abnormalities of gastric myoelcctrical activity in patients with type I di- abetes mellitus[J]. Gastroenterology, 1994,107(5) : 1390-1397.
  • 3Gomella TL,Cunningham MD,Eyal FG,et al. Neonatology: management, procedures, on-call problems, diseases and drugs[M]. 5th Ed. New York: McGraw-Hill Companies, Inc, 2004 : 294-295.
  • 4Lawlor MA,Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?[J]. J Cell Sci,2001,114 (Pt 16): 2903-2910.
  • 5McKeehan WL,Adams PS,Rosser MP. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture[J]. Cancer Res, 1984,44(5 ) : 1998-2010.
  • 6Doppenberg EM,Zanner A,Bullock R,et al. Correlations between brain tissue oxygen tension, carbon dioxide tension, pI-I, and cerebral blood flow--a better way of monitoring the severely injured brain?[J]. Surg Neurol, 1998,49(6):650-654.
  • 7Yudkin JS,Panahloo A,Stehouwer C,et al. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects[J]. Diabetologia, 2000,43(9) : 1099-1106.
  • 8Magsino CH Jr,Hamouda W,Ghanim H,et al. Effect of triiodothyronine on reactive oxygen species generation by leukocytes, indices of oxidative damage, and antioxidant reserve[J]. Metabolism, 2000,49(6) : 799-803.
  • 9潘晓明,吴宗贵,黄佐,任雨笙,张家友,李洪涛.胰岛素对人外周血单个核细胞肿瘤坏死因子α蛋白表达及分泌的影响以及普伐他汀的干预作用[J].中国动脉硬化杂志,2004,12(5):559-561. 被引量:1
  • 10刘琰,章雄,张志,方培耀,许伟石.局部应用胰岛素对烫伤大鼠创面愈合的影响[J].中华烧伤杂志,2004,20(2):98-101. 被引量:47

二级参考文献16

  • 1尤育初,孔进发,钱林法,赵承彦,杨俊红,王西华.^(125)I-人胸腺素的标记及其在小鼠体内的分布与代谢研究——Ⅰ.应用预载的IODO-BEAD进行人胸腺素^(125)I标记[J].中国生化药物杂志,1996,17(2):70-72. 被引量:1
  • 2中国原子能科学研究院,125I-胰岛素放射免疫分析药盒说明书,1997年
  • 3王树歧,药物生物技术,1996年,3卷,1期,18页
  • 4王浩丹,生物医学标记示踪技术,1995年,69页
  • 5Haffner SM, D'Agostino RJr, Mykkanen L, Tracy R, Howard B, Rewers M, et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care, 1999, 22: 562-568
  • 6Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation, 2000, 101: 975-980
  • 7Frystyk J, Ledet T, Moller N, Flyvbjerg A, Orskov H. Cardiovascular disease and insulin-like growth factor I. Circulation, 2002, 106: 893-895
  • 8Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care, 2002, 5: 551-559
  • 9Tagami S, Inokuchi JJ, Kabayama K, Yoshimura H, Kitamura F, Uemura S, et al. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem, 2002, 277: 3 085-092
  • 10Herman WH, Alexander CM, Cook JR, Boccuzzi SJ, Musliner TA, Pedersen TR, et al. Effect of simvastatin treatment on cardiovascular resource ultilization impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care, 1999, 22: 1 771-778

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部